Skip to main content
FT

Forward Therapeutics

Forward Therapeutics is a biopharmaceutical company focused on developing oral agents that target chronic inflammatory disorders through validated immunology pathways. Their approach aims to enhance patient access to effective treatments, addressing the significant unmet need for improved management of these conditions.

Palm Beach Gardens, United StatesFounded 202210700+ followers
Updated 20 months ago

Funding

$58M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BV
Funding rounds are not available yet.

Founders

Product

Problem

Chronic inflammatory disorders require long-term management, but current treatments may have limited efficacy or significant side effects, impacting patient quality of life. There is a need for more targeted and accessible oral therapies that can effectively modulate the immune system without causing widespread immunosuppression.

Solution

Forward Therapeutics is developing a portfolio of oral agents designed to selectively target validated immunology pathways involved in chronic inflammatory diseases. Their approach focuses on creating treatments that are both effective and convenient for patients, with the goal of improving disease management and overall outcomes. By targeting specific immune mechanisms, Forward Therapeutics aims to minimize off-target effects and enhance the therapeutic window of their drug candidates. The company's integrated discovery and development platform leverages cutting-edge capabilities and scientific expertise to advance promising molecules from preclinical stages through clinical trials.

Target Audience

The primary target audience includes patients suffering from chronic inflammatory disorders, as well as physicians and specialists seeking more effective and accessible treatment options.

Features

  • Orally administered drugs for convenient patient access
  • Focus on validated immunology targets to increase therapeutic potential
  • Selective modulation of immune pathways to minimize side effects
  • Integrated discovery and development platform for efficient drug advancement
This profile is AI-generated and may contain inaccuracies.